Suppression of Histamine Signaling by Probiotic Lac-B : a Possible Mechanism of Its Anti-allergic Effect
スポンサーリンク
概要
- 論文の詳細を見る
It has been shown that probiotic bacteria are effective for the treatment of allergic diseases. As histamine plays a central role in allergic diseases, it is possible that probiotic bacteria affect the allergy-related histamine signaling. Here, we investigated the effect of Lac-B, a mixture of freeze-dried Bifidobacterium infantis and Bifidobacterium longum, on the allergy-related histamine signaling. In the nasal allergy model rats made by sensitization and provocation with toluene 2,4-diisocyanate (TDI) for 3 weeks, TDI provocation caused acute allergy–like behaviors along with significant up-regulation of histamine H1 receptor (H1R) and histidine decarboxylase (HDC) mRNA expression, increased HDC activity, histamine content, and [3H]mepyramine binding activity in nasal mucosa. Prolonged treatment with Lac-B (40 mg/rat, p.o.) significantly suppressed both the allergy-like behaviors and all of the above mentioned factors involved in histamine signaling. Our findings indicate that oral administration of Lac-B showed significant anti-allergic effect through suppression of both H1R and HDC gene expression followed by decrease in H1R, HDC protein level, and histamine content. Suppression of histamine signaling may be a novel target of probiotics in preventing allergic diseases.
- 社団法人 日本薬理学会の論文
- 2008-06-20
著者
-
Mizuguchi Hiroyuki
Department of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka
-
FUKUI Hiroyuki
Department of Pharmacology, Faculty of Pharmaceutical Sciences, The University of Tokushima
-
MATSUSHITA Chiyo
Department of Molecular Pharmacology, Institute of Health Biosciences, The University of Tokushima G
-
FUKUI Hiroyuki
Yao Municipal Hospital
-
Matsushita Chiyo
Department Of Molecular Pharmacology The University Of Tokushima Graduate School
-
Matsushita Chiyo
Department Of Molecular Pharmacology Institute Of Health Biosciences The University Of Tokushima Gra
-
Fukui Hiroyuki
Department Of Molecular Pharmacology The University Of Tokushima Graduate School
-
Fukui Hiroyuki
徳島大学 ヘルスバイオサイエンス研究部耳鼻咽喉科学
-
Das Asish
Dep. Of Molecular Pharmacology Inst. Of Health-biosciences The Univ. Of Tokushima Graduate School Jp
-
DEV Shrabanti
Department of Molecular Pharmacology, Institute of Health-Biosciences, The University of Tokushima G
-
DAS Asish
Department of Molecular Pharmacology, Institute of Health-Biosciences, The University of Tokushima G
-
MAEYAMA Kazutaka
Division of Pharmacology, Department of Integrated Basic Medical Science, Ehime University School of
-
UMEHARA Hayato
Department of Molecular Pharmacology, Institute of Health-Biosciences, The University of Tokushima G
-
OHTOSHI Takayuki
Ohtoshi Clinic
-
KOJIMA Jun
Clinical Research Group, Clinical Development Department, Kowa Pharmaceutical Co., Ltd.
-
NISHIDA Kiyotaka
Clinical Research Group, Clinical Development Department, Kowa Pharmaceutical Co., Ltd.
-
TAKAHASHI Kunihiko
Clinical Research Group, Clinical Development Department, Kowa Pharmaceutical Co., Ltd.
-
Das Asish
Department Of Molecular Pharmacology Graduate School Of Health Biosciences The University Of Tokushi
-
Takahashi Kunihiko
Clinical Research Group Clinical Development Department Kowa Pharmaceutical Co. Ltd.
-
Dev Shrabanti
Department Of Molecular Pharmacology The University Of Tokushima Graduate School
-
Das Asish
Departments Of Molecular Pharmacology Graduate School Of Health-biosciences The University Of Tokush
-
Umehara Hayato
Department Of Molecular Pharmacology The University Of Tokushima Graduate School
-
Mizuguchi Hiroyuki
Department Of Molecular Pharmacology The University Of Tokushima Graduate School
-
Fukui Hiroyuki
Department Of Molecular Pharmacology Institute Of Health Biosciences The University Of Tokushima Gra
-
Maeyama Kazutaka
Division Of Pharmacology Department Of Integrated Basic Medical Science Ehime University School Of M
-
Maeyama Kazutaka
Division Of Pharmacology Department Of Integrated Basic Medical Science Ehime University School Of M
-
Kojima Jun
Clinical Research Group Clinical Development Department Kowa Pharmaceutical Co. Ltd.
-
Fukui Hiroyuki
Department Of Medicine Yao City Hospital
-
Nishida Kiyotaka
Clinical Research Group Clinical Development Department Kowa Pharmaceutical Co. Ltd.
関連論文
- 小青竜湯によるアレルギー性鼻炎モデルラットの症状抑制とヒスタミンシグナル遺伝子発現抑制作用
- MS38-#1 抗ヒスタミン薬を用いた花粉症初期療法におけるヒスタミンH_1受容体遺伝子発現の意義(アレルギー性鼻炎-病態生理と治療4-花粉症の病態を中心に-,第59回日本アレルギー学会秋季学術大会)
- Optimized PEGylated Adenovirus Vector Reduces the Anti-vector Humoral Immune Response against Adenovirus and Induces a Therapeutic Effect against Metastatic Lung Cancer
- 鼻過敏症動物モデルにおける鼻粘膜ヒスタミンH1受容体mRNA発現上昇とヒスタミンH1受容体拮抗薬による抑制
- PKCによるヒスタミンH_1受容体のリン酸化
- 190 抗ヒスタミン薬によるヒスチジン脱炭酸酵素遺伝子発現抑制を介する新規アレルギー疾患治療戦略(Chemical mediators,シグナル伝達2,一般演題(デジタルポスター),第57回日本アレルギー学会秋季学術大会)
- 7.ラット,モルモットDDCのクローニング(ビタミンB_6酵素を楽しむ会研究発表要旨,ビタミンB_6酵素研究会)
- Anti-tumor Responses Induced by Chemokine CCL19 Transfected into an Ovarian Carcinoma Model via Fiber-Mutant Adenovirus Vector(Biopharmacy)
- ヒスタミン受容体 (脳における情報伝達--神経機能素子と素過程) -- (興奮の伝導と伝達 神経伝達物質受容体)
- Identification of GFAT1-L, a novel splice variant of human glutamine : fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle
- 336 トシル酸スプラタストの鼻過敏症モデルラット鼻粘膜ヒスタミンH_1受容体及びヒスタミンレベル抑制作用(花粉症,鼻アレルギー4,第58回日本アレルギー学会秋季学術大会)
- 237 抗ヒスタミン薬早期投与によるアレルギーモデルラット鼻粘膜のヒスタミンH_1受容体mRNA上昇に対する抑制作用(花粉症5,一般演題(口演),第56回日本アレルギー学会秋季学術大会)
- Identification of epigallocatechin-3-O-gallate as an active constituent in tea extract that suppresses transcriptional up-regulations of the histamine H_1 receptor and interleukin-4 genes
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Binding cells of ^I-iodoamphetamine in rat liver
- S3-2 ヒスタミンH1受容体遺伝子発現の亢進メカニズムと花粉症初期療法の分子機構(S3 アレルギー性鼻炎/花粉症研究の最前線,シンポジウム,第60回日本アレルギー学会秋季学術大会)
- P9-1 苦参に含まれる遺伝子発現抑制物質(P9 鼻炎・結膜炎・病態,ポスター,第60回日本アレルギー学会秋季学術大会)
- Zucker fatty ラットを用いたSTZ誘発性2型糖尿病モデルの解析
- P181 ロイコトリエン受容体拮抗薬投与による鼻粘膜H1受容体発現up-regulatiOnのメカニズムの解明(花粉症3,第20回日本アレルギー学会春季臨床大会)
- Effect of Endothelin-1 (1-31) on Human Mesangial Cell Proliferation
- B-09 鼻過敏症モデルラット鼻粘膜におけるアレルギー疾患関連遺伝子発現亢進及び鼻炎症状に対する乳酸菌の抑制作用(免疫・アレルギー,一般演題口演,第24回和漢医薬学会大会 和漢薬の複雑さ-経験知と科学知-)
- 326 鼻過敏症モデルラットにおけるヒスタミンH1受容体およびヒスチジン脱炭酸酵素の遺伝子発現
- ヒスタミンH_1受容体遺伝子発現機構を標的とするアレルギー疾患治療薬の意義(誌上シンポジウム)
- EVS3-2 鼻過敏症モデルラット鼻粘膜におけるヒスタミンH_1受容体遺伝子発現亢進とその機構(イブニングシンポジウム3 上下気道連関から見たアレルギー性鼻炎の治療戦略,第56回日本アレルギー学会秋季学術大会)
- アレルギー疾患関連遺伝子としてのヒスタミンH1受容体遺伝子 (特集 アレルギー炎症反応におけるヒスタミンの役割と抗ヒスタミン薬)
- 216 自律神経伝達物質受容体を介するヒスタミンH_1受容体遺伝子発現調節(シグナル伝達, 第55回日本アレルギー学会秋季学術大会)
- 1 アレルギー関連遺伝子としてのヒスタミンH_1受容体およびヒスチジン脱炭酸酵素の研究(17 アレルギー・免疫に及ぼすヒスタミン機能の新展開, 第55回日本アレルギー学会秋季学術大会)
- 司会のことば(17 アレルギー・免疫に及ぼすヒスタミン機能の新展開, 第55回日本アレルギー学会秋季学術大会)
- ヒスタミンH_1受容体の発現調節機構とその意義
- 序文
- ヒスタミンH_1受容体遺伝子発現調節機構の薬物標的としての意義
- 1P35 物理化学的手法によるヒスタミンH1受容体の立体構造予測
- 7回膜貫通型レセプタ-とシグナル伝達
- 脳内セロトニン神経系の分布(眼で見るペ-ジ-299-)
- 9 モルモット血管内皮細胞及び血管平滑筋細胞におけるヒスタミンH_1-レセプターの解析
- ヒスタミンH1,H2-受容体の分子生物学 (ヒスタミン)
- Kujin Suppresses Histamine Signaling at the Transcriptional Level in Toluene 2,4-Diisocyanate-Sensitized Rats
- Repeated Pre-treatment With Antihistamines Causes Transcriptional Up-regulations of Histamine H_1 Receptor and Interleukin-4 Genes in Toluene-2,4-diisocyanate-Sensitized Rats
- Evaluation of Efficacy and Sedative Profiles of H_1 Antihistamines by Large-Scale Surveillance Using the Visual Analogue Scale (VAS)
- 教1-2 疾患感受性遺伝子発現亢進機構研究と新規治療薬開発のためのアレルギー性鼻炎モデルラット(動物モデルの可能性と限界,教育講演,教育コース1(薬理学1),第22回日本アレルギー学会春季臨床大会)
- Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats
- Suppression of Histamine Signaling by Probiotic Lac-B : a Possible Mechanism of Its Anti-allergic Effect
- Identification of Amino Acid Residues Responsible for Agonist-Induced Down-Regulation of Histamine H_1 Receptors
- ヒスタミンH_1受容体のリガンド認識機構
- Purification and Characterization of [^3H] Mepyramine (Histamine H_1 Antagonist)-Binding Protein from Rat Liver: A Highly Homologous Protein with Cytochrome P450 2D
- Stimulation of Histamine H_1 Receptor Up-Regulates Histamine H_1 Receptor Itself Through Activation of Receptor Gene Transcription
- Recent Advances in Molecular Pharmacology of the Histamine Systems : Regulation of Histamine H_1 Receptor Signaling by Changing Its Expression Level
- Homologous and Heterologous Phosphorylations of Human Histamine H_1 Receptor in Intact Cells
- Histamine H_1 Receptor Down-Regulation Mediated by M_3 Muscarinic Acetylcholine Receptor Subtype
- β_2-Adrenergic Receptor-Mediated Histamine H_1 Receptor Down-Regulation : Another Possible Advantage of β_2 Agonists in Asthmatic Therapy
- Adenovirus Vector Covalently Conjugated to Polyethylene Glycol with a Cancer-Specific Promoter Suppresses the Tumor Growth through Systemic Administration
- Dexamethasone Suppresses Histamine Synthesis by Repressing both Transcription and Activity of HDC in Allergic Rats
- Recent Advances in Molecular Pharmacology of the Histamine Systems : Organic Cation Transporters as a Histamine Transporter and Histamine Metabolism
- Characterization of Polymorphs of a Novel Quinolinone Derivative, TA-270(4-Hydroxy-1-methyl-3-octyloxy-7-sinapinoylamino-2(1H)-quinolinone)
- スギ花粉症に対する初期療法 (特集 遺伝子解析からアレルギー疾患の治療戦略を考える)
- Structure of Imidazole Glycerol Phosphate Synthase from Thermus thermophilus HB8 : Open-Closed Conformational Change and Ammonia Tunneling
- Glutamine : phenylpyruvate Aminotransferase from an Extremely Thermophilic Bacterium, Thermus thermophilus HB8
- Functionally Important Residues of Aromatic L-Amino Acid Decarboxylase Probed by Sequence Alignment and Site-Directed Mutagenesis
- Localized Expression of Histamine H_1 Receptors in Syncytiotrophoblast Cells of Human Placenta
- Progress in Allergy Signal Research on Mast Cells : Up-Regulation of Histamine Signal-Related Gene Expression in Allergy Model Rats
- ヒスタミンH_1受容体遺伝子発現亢進の病理学的意義
- Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
- MS24-1 花粉症におけるアレルギー疾患感受性遺伝子群(MS24 アレルギー性鼻炎の研究の進歩,ミニシンポジウム,第61回日本アレルギー学会秋季学術大会)
- ヒスタミンH1受容体遺伝子発現の亢進メカニズムと花粉症初期療法の分子機構 (特集 花粉症研究の最前線)
- Inverse Agonistic Activity of Antihistamines and Suppression of Histamine H_1 Receptor Gene Expression
- Histamine H1-Receptor Down-Regulation Mediated by M3 Muscarinic Acetylcholine Receptor Subtype
- O34-5 抗アレルギー和漢薬苦参由来PKCδシグナル抑制薬,(-)マーキアインの分子薬理機構(アレルギー治療薬,口演,第62回日本アレルギー学会秋季学術大会)
- Combination of Leukotoriene Receptor Antagonist With Antihistamine Has an Additive Suppressive Effect on the Up-regulation of H1-Receptor mRNA in the Nasal Mucosa of Toluene 2,4-Diisocyanate-Sensitized Rat
- S5-1 ヒスタミン受容体の役割(S5 アレルギー性鼻炎の発症メカニズムと治療,シンポジウム5,第25回日本アレルギー学会春季臨床大会)
- Dependency of histamine induced phasic and tonic contractions on intracellular and extracellular calcium in guinea pig tracheal smooth muscle.
- Functional expression of H1-histaminergic receptors in Xenopus laevis oocytes injected with bovine adrenal medullary mRNA.
- S1-3 Clinical significance of antihistamines(Antihistamine update (English Session))
- Identification of epigallocatechin-3-O-gallate as an active constituent in tea extract that suppresses transcriptional up-reguiations of the histamine H_1 receptor and interleukin-4 genes